Critical factors influencing clinical trial enrollment and autologous stem cell transplantation in African-American patients with multiple myeloma: A retrospective, interview-based analysis

被引：0
作者：
Williams, Louis
Hurwitz, Heathe M.
Onger, Tiffany
Basali, Diana
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2023年 / 32卷 / 12期
关键词：
D O I：
10.1158/1538-7755.DISP23-A063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A063
引用
收藏
页数：2
相关论文
共 50 条
  • [21] What are the factors affecting survival after autologous stem cell transplantation in patients with multiple myeloma?
    Solmaz, Serife
    Acar, Celal
    Seyhanli, Ahmet
    Sevindik, Omur Gokmen
    Piskin, Ozden
    Ozcan, Mehmet Ali
    Demirkan, Fatih
    Undar, Buelent
    Alacacioglu, Inci
    Ozsan, Guner Hayri
    INDIAN JOURNAL OF TRANSPLANTATION, 2020, 14 (01) : 57 - 62
  • [22] Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma *
    Bolaman, Ali Z.
    Turgutkaya, Atakan
    Yavasoglu, Irfan
    PLASMATOLOGY, 2021, 15
  • [23] IMPROVED OUTCOME OF AFRICAN AMERICAN MULTIPLE MYELOMA PATIENTS WITH NOVEL AGENTS AND AUTOLOGOUS STEM CELL TRANSPLANT
    Saraf, S.
    Patel, P.
    Ozer, H.
    Peace, D.
    Quigley, J.
    Mahmud, N.
    Rondelli, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S296 - S297
  • [24] Survival Disparities Between African American and Caucasian Patients With Multiple Myeloma Are Blunted in the Era of Novel Therapeutics and Autologous Stem Cell Transplantation
    Shah, Nina
    Weber, Donna M.
    Wang, Michael
    Thomas, Sheeba
    Shah, Jatin
    Giralt, Sergio
    Alexanian, Raymond
    Orlowski, Robert Z.
    Qazilbash, Muzaffar H.
    Avery, Tiffany
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03) : E31 - E31
  • [25] Efficacy and Safety of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma: A Retrospective SingleCenter Analysis in China
    Wu, Shunquan
    Qiu, Zongjian
    Zhan, Rong
    Li, Xiaofan
    Chen, Ping
    Chen, Xianling
    Li, Nainong
    BLOOD, 2022, 140 : 12934 - 12935
  • [26] Single-Center Analysis of Factors Predicting Outcome after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
    Petrova, G. D. L.
    Chernyavskaya, T.
    Doronin, V.
    Mkheidze, D.
    Melkova, K.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S307 - S307
  • [27] Independent factors influencing the outcome after allogeneic stem cell transplantation in patients with relapsed multiple myeloma: A retrospective single-center analysis in 98 patients
    Mielke, S.
    Schemmel, L. -K
    Schreder, M.
    Grigoleit, G. -U
    Rasche, L.
    Boenig, H.
    Stuhler, G.
    Einsele, H.
    Knop, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 205 - 205
  • [28] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA PATIENTS AGED 65 YEARS OR OLDER: A RETROSPECTIVE SINGLE INSTITUTIONAL ANALYSIS
    Minoia, C.
    Pisapia, G.
    Palazzo, G.
    Ingrosso, C.
    Buonanno, M.
    Spinosa, C.
    Prudenzano, A.
    Pricolo, G.
    Mazza, P.
    HAEMATOLOGICA, 2015, 100 : 175 - 175
  • [29] Preemptive plerixafor based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation
    Vadlamani, Surya Prakash
    Kumar, Lalit
    Pramanik, Raja
    Varshney, Ankur Nandan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E303 - E303
  • [30] Prospective identification of potential factors influencing stem cell mobilization and the necessity for plerixafor use in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation
    Ray, Gopal Krushna
    Jena, Rabindra Kumar
    Panda, Tribikram
    Sethy, Sudha
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (04) : 402 - 409
12345